CO5180591A1 - Derivados de 4 carbamato-6-deoxi-a-l-xilo-2-hexulofuranosa . - Google Patents
Derivados de 4 carbamato-6-deoxi-a-l-xilo-2-hexulofuranosa .Info
- Publication number
- CO5180591A1 CO5180591A1 CO00001575A CO00001575A CO5180591A1 CO 5180591 A1 CO5180591 A1 CO 5180591A1 CO 00001575 A CO00001575 A CO 00001575A CO 00001575 A CO00001575 A CO 00001575A CO 5180591 A1 CO5180591 A1 CO 5180591A1
- Authority
- CO
- Colombia
- Prior art keywords
- derivatives
- compounds
- xyl
- isopropylidene
- alkyne
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- -1 diastereomers Chemical class 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 150000001336 alkenes Chemical class 0.000 abstract 2
- 150000001345 alkine derivatives Chemical class 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 230000021164 cell adhesion Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000007170 pathology Effects 0.000 abstract 2
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 101100294106 Caenorhabditis elegans nhr-3 gene Proteins 0.000 abstract 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 125000002877 alkyl aryl group Chemical class 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 125000006501 nitrophenyl group Chemical group 0.000 abstract 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 201000003068 rheumatic fever Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 125000003944 tolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN86DE1999 IN190975B (cg-RX-API-DMAC7.html) | 1999-01-15 | 1999-01-15 | |
| US09/276,368 US6590085B1 (en) | 1999-01-15 | 1999-03-25 | Derivatives of monosaccharides as cell adhesion inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5180591A1 true CO5180591A1 (es) | 2002-07-30 |
Family
ID=11088155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO00001575A CO5180591A1 (es) | 1999-01-15 | 2000-01-14 | Derivados de 4 carbamato-6-deoxi-a-l-xilo-2-hexulofuranosa . |
Country Status (30)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN190975B (cg-RX-API-DMAC7.html) * | 1999-01-15 | 2003-09-06 | Ranbaxy Lab Ltd | |
| NZ577031A (en) | 2003-05-30 | 2010-09-30 | Ranbaxy Lab Ltd | Substituted pyrrole derivatives and their use as HMG-CO inhibitors |
| WO2006024926A1 (en) * | 2004-09-02 | 2006-03-09 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
| WO2007063356A2 (en) * | 2004-12-22 | 2007-06-07 | Ranbaxy Laboratories Limited | Derivatives of pentose monosaccharides as anti-inflammatory compounds |
| US20090054519A1 (en) * | 2005-07-22 | 2009-02-26 | Abhijit Ray | Derivatives of monosaccharides as 5-lipoxygenase inhibitors |
| BRPI0618379A2 (pt) * | 2005-11-08 | 2011-08-30 | Ranbaxy Lab Ltd | processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico |
| CL2007000667A1 (es) * | 2006-03-14 | 2008-03-14 | Ranbaxi Lab Ltd | Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e |
| US20080114031A1 (en) * | 2006-03-29 | 2008-05-15 | Sattigeri Viswajanani J | Monosaccharide derivatives |
| EP1864992A2 (en) * | 2006-05-30 | 2007-12-12 | Ranbaxy Laboratories, Ltd. | Monosaccharide derivatives |
| EP1953170A1 (en) * | 2006-10-03 | 2008-08-06 | Ranbaxy Laboratories Limited | Monosaccharide derivatives as anti-inflammatory agents |
| AU2008221506B2 (en) * | 2007-09-20 | 2011-01-20 | ResMed Pty Ltd | Retractable Tube for CPAP |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2715121A (en) | 1950-09-09 | 1955-08-09 | American Home Prod | Alkyl sugar derivatives and their preparation |
| US4056322A (en) | 1973-12-14 | 1977-11-01 | Strategic Medical Research Corporation | Preparation of ethers of monosaccharides |
| US4735934A (en) | 1981-02-17 | 1988-04-05 | Greenwich Pharmaceuticals Incorporated | Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease |
| US4996195A (en) * | 1989-01-09 | 1991-02-26 | Greenwich Pharmaceuticals Inc. | Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives |
| US5010058A (en) * | 1989-06-22 | 1991-04-23 | 501 Greenwich Pharmaceuticals Incorporated | 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives |
| FR2652540B1 (fr) | 1989-10-02 | 1995-06-02 | Imaje Sa | Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre. |
| US5192746A (en) | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
| US5258402A (en) | 1992-06-11 | 1993-11-02 | Mcneil-Ppc, Inc. | Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
| US5432163A (en) | 1992-11-13 | 1995-07-11 | Greenwich Pharmaceuticals Incorporated | Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
| US5637570A (en) * | 1995-05-09 | 1997-06-10 | Chemora Pharmochem | Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity |
| IN190975B (cg-RX-API-DMAC7.html) * | 1999-01-15 | 2003-09-06 | Ranbaxy Lab Ltd |
-
1999
- 1999-01-15 IN IN86DE1999 patent/IN190975B/en unknown
- 1999-03-25 US US09/276,368 patent/US6590085B1/en not_active Expired - Fee Related
-
2000
- 2000-01-10 SK SK10132001A patent/SK284241B6/sk unknown
- 2000-01-10 CA CA002359986A patent/CA2359986A1/en not_active Abandoned
- 2000-01-10 AR ARP000100086A patent/AR022235A1/es not_active Application Discontinuation
- 2000-01-10 DK DK00900088T patent/DK1147119T3/da active
- 2000-01-10 HU HU0105116A patent/HUP0105116A3/hu unknown
- 2000-01-10 HR HR20010529A patent/HRP20010529B1/xx not_active IP Right Cessation
- 2000-01-10 MX MXPA01007187A patent/MXPA01007187A/es not_active IP Right Cessation
- 2000-01-10 YU YU50701A patent/YU50701A/sh unknown
- 2000-01-10 NZ NZ512852A patent/NZ512852A/xx unknown
- 2000-01-10 CZ CZ20012540A patent/CZ20012540A3/cs unknown
- 2000-01-10 CN CNB008048525A patent/CN1167707C/zh not_active Expired - Fee Related
- 2000-01-10 ID IDW00200101520A patent/ID30351A/id unknown
- 2000-01-10 AT AT00900088T patent/ATE250074T1/de not_active IP Right Cessation
- 2000-01-10 TR TR2001/02043T patent/TR200102043T2/xx unknown
- 2000-01-10 PT PT00900088T patent/PT1147119E/pt unknown
- 2000-01-10 EP EP00900088A patent/EP1147119B1/en not_active Expired - Lifetime
- 2000-01-10 ES ES00900088T patent/ES2206176T3/es not_active Expired - Lifetime
- 2000-01-10 NZ NZ527483A patent/NZ527483A/en unknown
- 2000-01-10 DE DE60005300T patent/DE60005300T2/de not_active Expired - Fee Related
- 2000-01-10 AU AU18861/00A patent/AU768511B2/en not_active Ceased
- 2000-01-10 WO PCT/IB2000/000022 patent/WO2000042054A1/en not_active Ceased
- 2000-01-10 BR BR0007553-1A patent/BR0007553A/pt not_active IP Right Cessation
- 2000-01-10 JP JP2000593621A patent/JP2002534530A/ja active Pending
- 2000-01-14 MY MYPI20000121A patent/MY121135A/en unknown
- 2000-01-14 PA PA20008489901A patent/PA8489901A1/es unknown
- 2000-01-14 CO CO00001575A patent/CO5180591A1/es not_active Application Discontinuation
-
2001
- 2001-07-12 CR CR6423A patent/CR6423A/xx not_active Application Discontinuation
- 2001-07-12 MA MA26266A patent/MA25342A1/fr unknown
- 2001-07-26 BG BG105745A patent/BG105745A/xx unknown
-
2003
- 2003-07-01 US US10/611,093 patent/US7005422B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/611,386 patent/US7005516B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/610,719 patent/US7037899B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/611,091 patent/US20040018995A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5180591A1 (es) | Derivados de 4 carbamato-6-deoxi-a-l-xilo-2-hexulofuranosa . | |
| AR014903A1 (es) | Compuestos del tipo 4-amino-fenilalanina inhibidores de la adhesion de leucocitos intermediada por vla-4, compuesto que son droga de dichos compuestos,composiciones farmaceuticas, metodo para adherir vla-4 en una muestra biologica, metodo para tratar una condicion inflamatoria | |
| ES8404322A1 (es) | Un procedimiento para la preparacion de derivados de acidos alcanoicos. | |
| CA1258464A (en) | 1,3-dioxan-5-ylalkenoic acids | |
| PE107698A1 (es) | Amidas de acido fosfinico como inhibidores de metaloproteasas de matriz | |
| NO950849D0 (no) | Derivater av valproin og 2-valproensyreamider og anvendelse som antikonvulsanter | |
| ES2149043T3 (es) | Compuestos glicerolipidicos utiles para la transferencia de una substancia activa a una celula diana. | |
| Yang et al. | Simple synthesis of sulfonyl chlorides from thiol precursors and derivatives by NaClO2-mediated oxidative chlorosulfonation | |
| AR009543A1 (es) | Fragmento estructural derivado del acido carbonico, derivados que lo incluyen, metodo de preparacion de derivado utiles como material de partida yuso de dichos derivados. | |
| AR041861A1 (es) | Feniliso (tio) cianatos, procesos e intermediarios para su preparacion. | |
| KR930023329A (ko) | 시클로펜탄- 및- 펜텐- β- 아미노산 | |
| HUT39966A (en) | Insecticides containing as active substance acetilized sacharin-derivatives and process for production of this active substance | |
| HUP0200689A2 (hu) | Eljárás aril-alkil-éterek előállítására | |
| ES8607960A1 (es) | Procedimiento para preparar acidos aroil-benzofuran y benzo-tiofen-aceticos y-propionicos | |
| ES8703825A1 (es) | Un procedimiento para la preparacion de derivados del acido fenil nonatetraenoico | |
| ES8207130A1 (es) | Un metodo para la preparacion de derivados del acido prope- noico. | |
| ES2031514T3 (es) | 2-guanidino-4-ariltiazoles para el tratamiento de ulceras pepticas. | |
| GB0208176D0 (en) | Organic compounds | |
| JPS643162A (en) | Sulfonamide compound | |
| PE2099A1 (es) | Derivados de acido hidroxamico | |
| ES2098370T3 (es) | Derivado del acido epoxisuccinamico. | |
| ES481493A1 (es) | Procedimiento para la preparacion de acidos acil(arilbici- clico) aminoalcanoicos. | |
| ATE268177T1 (de) | Substituierte 1-(piperidin-4-yl)-3-(aryl)- isothioharnstoffe , ihre herstellung und therapeutische verwendung | |
| ES8401761A1 (es) | Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos. | |
| ID16173A (id) | Proses kimia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |